1 - 25 of
379
results
for author:"Johnson M."
in Literature Citations
| Human dectin-1 deficiency and mucocutaneous fungal infections. Ferwerda B., Ferwerda G., Plantinga T.S., Willment J.A., van Spriel A.B., Venselaar H., Elbers C.C., Johnson M.D., Cambi A., Huysamen C. et al. N. Engl. J. Med. 361:1760-1767(2009) · Mapped (6) |
| Tumor suppressor function of Syk in human MCF10A in vitro and normal mouse mammary epithelium in vivo. Sung Y.M., Xu X., Sun J., Mueller D., Sentissi K., Johnson P., Urbach E., Seillier-Moiseiwitsch F., Johnson M.D., Mueller S.C. PLoS ONE 4:e7445-e7445(2009) · Mapped (3) |
| Nuclear magnetic resonance structure of the nucleic acid-binding domain of severe acute respiratory syndrome coronavirus nonstructural protein 3. Serrano P., Johnson M.A., Chatterjee A., Neuman B.W., Joseph J.S., Buchmeier M.J., Kuhn P., Wuthrich K. J. Virol. 83:12998-13008(2009) · Mapped (1) |
| Bone morphogenetic protein 4 and its receptors are expressed in the leptomeninges and meningiomas and signal via the Smad pathway. Johnson M.D., O'Connell M.J., Vito F., Pilcher W. J. Neuropathol. Exp. Neurol. 68:1177-1183(2009) · Mapped (2) |
| Glutaredoxins: roles in iron homeostasis. Rouhier N., Couturier J., Johnson M.K., Jacquot J.P. Trends Biochem. Sci. 0:0-0(2009) · Mapped (9) |
| Structural and functional characteristics of xenavidin, the first frog avidin from Xenopus tropicalis. Maatta J.A., Helppolainen S.H., Hytonen V.P., Johnson M.S., Kulomaa M.S., Airenne T.T., Nordlund H.R. BMC Struct. Biol. 9:63-63(2009) · Mapped (1) |
| The yeast iron regulatory proteins Grx3/4 and Fra2 form heterodimeric complexes containing a [2Fe-2S] cluster with cysteinyl and histidyl ligation. Li H., Mapolelo D.T., Dingra N.N., Naik S.G., Lees N.S., Hoffman B.M., Riggs-Gelasco P.J., Huynh B.H., Johnson M.K., Outten C.E. Biochemistry 48:9569-9581(2009) · Mapped (5) |
| Endothelial response to childhood infection: The role of mannose-binding lectin (MBL). Charakida M., Donald A.E., Leary S., Halcox J.P., Turner M.W., Johnson M., Loukogeorgakis S.P., Okorie M.I., Smith G.D., Deanfield J.E. et al. Atherosclerosis 0:0-0(2009) · Mapped (3) |
| A shift from nuclear to cytoplasmic breast cancer metastasis suppressor 1 expression is associated with highly proliferative estrogen receptor-negative breast cancers. Frolova N., Edmonds M.D., Bodenstine T.M., Seitz R., Johnson M.R., Feng R., Welch D.R., Frost A.R. Tumour Biol. 30:148-159(2009) · Mapped (2) |
| The ERAP2 gene is associated with preeclampsia in Australian and Norwegian populations. Johnson M.P., Roten L.T., Dyer T.D., East C.E., Forsmo S., Blangero J., Brennecke S.P., Austgulen R., Moses E.K. Hum. Genet. 126:655-666(2009) · Mapped (59) |
| Differences in expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 and 2 in human placentas of term pregnancies according to birth weight and gender. Mericq V., Medina P., Kakarieka E., Marquez L., Johnson M.C., Iniguez G. Eur. J. Endocrinol. 161:419-425(2009) · Mapped (2) |
| Polarized epithelial cells secrete matriptase as a consequence of zymogen activation and HAI-1-mediated inhibition. Wang J.K., Lee M.S., Tseng I.C., Chou F.P., Chen Y.W., Fulton A., Lee H.S., Chen C.J., Johnson M.D., Lin C.Y. Am. J. Physiol., Cell Physiol. 297:C459-70(2009) · Mapped (8) |
| The relationships of ABCB1 3435C>T and CYP2B6 516G>T with high-density lipoprotein cholesterol in HIV-infected patients receiving Efavirenz. Mahungu T.W., Nair D., Smith C.J., Egan D., Youle M., Johnson M.A., Khoo S.H., Back D.J., Owen A. Clin. Pharmacol. Ther. 86:204-211(2009) · Mapped (13) |
| Identification of novel HMGA2 fusion sequences in lipoma: evidence that deletion of let-7 miRNA consensus binding site 1 in the HMGA2 3' UTR is not critical for HMGA2 transcriptional upregulation. Wang X., Hulshizer R.L., Erickson-Johnson M.R., Flynn H.C., Jenkins R.B., Lloyd R.V., Oliveira A.M. Genes Chromosomes Cancer 48:673-678(2009) · Mapped (10) |
| Anaplastic lymphoma kinase immunoreactivity correlates with ALK gene rearrangement and transcriptional up-regulation in non-small cell lung carcinomas. Boland J.M., Erdogan S., Vasmatzis G., Yang P., Tillmans L.S., Johnson M.R., Wang X., Peterson L.M., Halling K.C., Oliveira A.M. et al. Hum. Pathol. 40:1152-1158(2009) · Mapped (12) |
| Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population. Mahungu T., Smith C., Turner F., Egan D., Youle M., Johnson M., Khoo S., Back D.j., Owen A. HIV Med. 10:310-317(2009) · Mapped (34) |
| Differences in APOBEC3G expression in CD4+ T helper lymphocyte subtypes modulate HIV-1 infectivity. Vetter M.L., Johnson M.E., Antons A.K., Unutmaz D., D'Aquila R.T. PLoS Pathog. 5:e1000292-e1000292(2009) · Mapped (3) |
| The role of the neuropeptide Y2 receptor in liporemodeling: neuropeptide Y-mediated adipogenesis and adipose graft maintenance. Baker S.B., Cohen M., Kuo L., Johnson M., Al-Attar A., Zukowska Z. Plast. Reconstr. Surg. 123:486-492(2009) · Mapped (3) |
| DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping. de Leon J., Susce M.T., Johnson M., Hardin M., Maw L., Shao A., Allen A.C., Chiafari F.A., Hillman G., Nikoloff D.M. CNS Spectr 14:19-34(2009) · Mapped (21) |
| Genetic deficiency of complement isoforms C4A or C4B predicts improved survival of metastatic renal cell carcinoma. Zafar G.I., Grimm E.A., Wei W., Johnson M.M., Ellerhorst J.A. J. Urol. 181:1028-1034(2009) · Mapped (42) |
| Expression and activity of 11beta-hydroxysteroid dehydrogenase type 1 enzyme in subcutaneous and visceral adipose tissue of prepubertal children. Mericq V., Medina P., Bouwman C., Johnson M.C., Godoy J., Lopez T., Iniguez G. Horm. Res. 71:89-93(2009) · Mapped (1) |
| Genetic association of the activin A receptor gene (ACVR2A) and pre-eclampsia. Fitzpatrick E., Johnson M.P., Dyer T.D., Forrest S., Elliott K., Blangero J., Brennecke S.P., Moses E.K. Mol. Hum. Reprod. 15:195-204(2009) · Mapped (2) |
| Somatic mutations of ErbB4: selective loss-of-function phenotype affecting signal transduction pathways in cancer. Tvorogov D., Sundvall M., Kurppa K., Hollmen M., Repo S., Johnson M.S., Elenius K. J. Biol. Chem. 284:5582-5591(2009) · Mapped (8) |
| Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer. Callahan M.J., Nagymanyoki Z., Bonome T., Johnson M.E., Litkouhi B., Sullivan E.H., Hirsch M.S., Matulonis U.A., Liu J., Birrer M.J. et al. Clin. Cancer Res. 14:7667-7673(2008) · Mapped (12) |
| Lead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment. Miller L.M., Mayer S.C., Berger D.M., Boschelli D.H., Boschelli F., Di L., Du X., Dutia M., Floyd M.B., Johnson M. et al. Bioorg. Med. Chem. Lett. 19:62-66(2009) · Mapped (1) |
